TREATMENT OF ATYPICAL LEISHMANIASIS WITH INTERFERON-GAMMA RESULTING IN PROGRESSION OF KAPOSIS-SARCOMA IN AN AIDS PATIENT

被引:23
作者
ALBRECHT, H
STELLBRINK, HJ
GROSS, G
BERG, B
HELMCHEN, U
MENSING, H
机构
[1] UNIV HAMBURG, HOSP EPPENDORF, DERMATOL ABT, D-20246 HAMBURG, GERMANY
[2] UNIV HAMBURG, HOSP EPPENDORF, INST PATHOL, D-20246 HAMBURG, GERMANY
来源
CLINICAL INVESTIGATOR | 1994年 / 72卷 / 12期
关键词
ACQUIRED IMMUNODEFICIENCY SYNDROME; HUMAN IMMUNODEFICIENCY VIRUS; LEISHMANIA DONOVANII; VISCERAL LEISHMANIASIS; KALA-AZAR; INTESTINAL PATHOGENS; KAPOSIS SARCOMA; PARASITES; PARASITIC PATHOGENS; INTERFERON-GAMMA;
D O I
10.1007/BF00577752
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Visceral leishmaniasis (kala-azar) affecting HIV-infected patient is being reported in increasing frequency. A 40-year-old German bisexual patient with full-blown AIDS is described who presented with Kaposi's sarcoma, epigastric pain, diarrhea, and weight loss but without fever. Leishmania amastigotes were initially found in biopsies from stomach, duodenum, and a cutaneous Kaposi's sarcoma lesion but were later also recovered from bone marrow and lymph node. The patient received three courses of a combination of pentavalent antimony and interferon-gamma. In addition to the common side effects such as fever, thrombocytopenia, and elevated amylase and lipase, a vivid progression of the Kaposi's sarcoma was noted. Tumor progression was temporally closely associated with treatment with interferon-gamma. Because this phenomemon has also been observed in other patients, we advise caution when using interferon-gamma in patients with Kaposi's sarcoma.
引用
收藏
页码:1041 / 1047
页数:7
相关论文
共 44 条
  • [1] ALTES J, 1991, AM J GASTROENTEROL, V86, P1283
  • [2] VISCERAL LEISHMANIASIS - ANOTHER HIV-ASSOCIATED OPPORTUNISTIC INFECTION - REPORT OF 8 CASES AND REVIEW OF THE LITERATURE
    ALTES, J
    SALAS, A
    RIERA, M
    UDINA, M
    GALMES, A
    BALANZAT, J
    BALLESTEROS, A
    BUADES, J
    SALVA, F
    VILLALONGA, C
    [J]. AIDS, 1991, 5 (02) : 201 - 207
  • [3] BADARO R, 1986, LANCET, V1, P647
  • [4] NEW PERSPECTIVES ON A SUBCLINICAL FORM OF VISCERAL LEISHMANIASIS
    BADARO, R
    JONES, TC
    CARVALHO, EM
    SAMPAIO, D
    REED, SG
    BARRAL, A
    TEIXEIRA, R
    JOHNSON, WD
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1986, 154 (06) : 1003 - 1011
  • [5] TREATMENT OF VISCERAL LEISHMANIASIS WITH PENTAVALENT ANTIMONY AND INTERFERON-GAMMA
    BADARO, R
    FALCOFF, E
    BADARO, FS
    CARVALHO, EM
    PEDRALSAMPAIO, D
    BARRAL, A
    CARVALHO, JS
    BARRALNETTO, M
    BRANDELY, M
    SILVA, L
    BINA, JC
    TEIXEIRA, R
    FALCOFF, R
    ROCHA, H
    HO, JL
    JOHNSON, WD
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (01) : 16 - 21
  • [6] VISCERAL LEISHMANIASIS IN PATIENTS INFECTED WITH HUMAN IMMUNODEFICIENCY VIRUS (HIV)
    BERENGUER, J
    MORENO, S
    CERCENADO, E
    DEQUIROS, JCLB
    DELAFUENTE, AG
    BOUZA, E
    [J]. ANNALS OF INTERNAL MEDICINE, 1989, 111 (02) : 129 - 132
  • [7] BETZ P, 1990, PATHOLOGE, V11, P97
  • [8] PROGRESSION OF KAPOSIS-SARCOMA UNDER A COMBINED INTERFERON-BETA AND INTERFERON-GAMMA THERAPY IN AIDS PATIENTS
    BROCKMEYER, NH
    MERTINS, L
    GOOS, M
    [J]. KLINISCHE WOCHENSCHRIFT, 1990, 68 (24): : 1229 - 1229
  • [9] CELL-MEDIATED-IMMUNITY IN AMERICAN VISCERAL LEISHMANIASIS - REVERSIBLE IMMUNOSUPPRESSION DURING ACUTE INFECTION
    CARVALHO, EM
    TEIXEIRA, RS
    JOHNSON, WD
    [J]. INFECTION AND IMMUNITY, 1981, 33 (02) : 498 - 502
  • [10] ABSENCE OF GAMMA-INTERFERON AND INTERLEUKIN-2 PRODUCTION DURING ACTIVE VISCERAL LEISHMANIASIS
    CARVALHO, EM
    BADARO, R
    REED, SG
    JONES, TC
    JOHNSON, WD
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1985, 76 (06) : 2066 - 2069